| BOLT BIOTHERAPEUTICS |
| USA |
| Gesundheit |
| US0977022039 / A419U9 |
| 6LP0 (Frankfurt) / BOLT (NASDAQ) |
| FRA:6LP0, ETR:6LP0, 6LP0:GR, NASDAQ:BOLT |
| - |
| https://www.boltbio.com/ |
| - |
| 7.14 Mio. EUR |
| 3.03 Mio. EUR |
| 6.67 Mio. EUR |
| -28.88 Mio. EUR |
| -28.91 Mio. EUR |
| -15.41 EUR |
| 19.89 Mio. EUR |
| 10.31 Mio. EUR |
| -34.52 Mio. EUR |
| 3.28 |
| 0.07% |
| 47.12% |
| - |
| - |
| - |
| - |
| BOLT BIOTHERAPEUTICS, BOLT BIO, BOLT BIOTHERAPEUTIC |
| 04.04.26 |
|